Clinical Trials Directory

Trials / Completed

CompletedNCT02019459

Very Low Nicotine Cigarettes in Smokers With Schizophrenia

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
58 (actual)
Sponsor
Brown University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Smokers with serious mental illness including those with schizophrenia and bipolar disorder infrequently attempt and attain sustained smoking abstinence and have a 25-year shorter lifespan due to smoking-related illness. This study will examine whether reducing the nicotine content of cigarettes to non-addicting levels is a viable method of reducing smoking in smokers with serious mental illness. Smokers will be randomized to one of two experimental conditions: 1) very low nicotine content (VLNC) cigarettes or 2) normal nicotine content (NNC) cigarettes. Participants will be assessed for patterns of tobacco use, biomarkers of exposure, subjective responses (e.g., satisfaction, craving, withdrawal symptoms), psychiatric symptoms, cognitive performance, smoking cue reactivity and smoking topography.

Conditions

Interventions

TypeNameDescription
OTHERVery low nicotine content cigarettes
OTHERstandard nicotine content cigarettes

Timeline

Start date
2014-11-17
Primary completion
2017-08-31
Completion
2017-08-31
First posted
2013-12-24
Last updated
2018-04-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02019459. Inclusion in this directory is not an endorsement.